Evidence map›Paper›PMID 37471432›Full record

ArticlePloS one2023

Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways).

Nisreen A Alwan, Donna Clutterbuck, Marija Pantelic, Jasmine Hayer, Lere Fisher, Lyth Hishmeh, Melissa Heightman, Gail Allsopp, Dan Wootton, Asad Khan and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. People from ethnic minorities seeking help for long COVID: a qualitative study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2024
    Article
  3. Long COVID and Health Inequalities: What's Next for Research and Policy Advocacy?Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  4. Review
  5. Barriers to healthcare access and experiences of stigma: Findings from a coproduced Long Covid case-finding study.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  6. Accessing care for Long Covid from the perspectives of patients and healthcare practitioners: A qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2024
    Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 1 country.

Nisreen A AlwanSchool of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, United Kingdom.ORCID 0000-0002-4134-8463
Donna ClutterbuckSchool of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, United Kingdom.
Marija PantelicBrighton and Sussex Medical School, University of Sussex, Falmer, United Kingdom.
Jasmine HayerCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Lere FisherCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Lyth HishmehCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.ORCID 0000-0001-5851-2904
Melissa HeightmanUniversity College London Hospitals NHS Trust, London, United Kingdom.
Gail AllsoppRoyal College of General Practitioners, London, United Kingdom.
Dan WoottonInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Asad KhanCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Claire HastieCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Monique JacksonCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Clare RaynerCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Darren BrownCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.ORCID 0000-0002-4956-243X
Emily ParrettCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Geraint JonesCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.ORCID 0000-0003-0551-8768
Kerry SmithCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Rowan ClarkeCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Sammie McfarlandCommunity Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.
Mark GabbayNIHR Applied Research Collaboration North West Coast, Liverpool, United Kingdom.
Amitava BanerjeeInstitute of Health Informatics, University College London, London, United Kingdom.ORCID 0000-0001-8741-3411
STIMULATE-ICP Consortium
University of Liverpool · GBBrighton and Sussex Medical School · GBChelsea and Westminster Hospital NHS Foundation Trust · GBManchester University NHS Foundation Trust · GBRoyal College of General Practitioners · GBSalisbury NHS Foundation Trust · GBUniversity College London · GBUniversity College London Hospitals NHS Foundation Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimLong Covid is a significant public health concern with potentially negative implications for health inequalities. We know that those who are already socially disadvantaged in society are more exposed to COVID-19, experience the worst health outcomes and are more likely to suffer economically. We also know that these groups are more likely to experience stigma and have negative healthcare experiences even before the pandemic. However, little is known about disadvantaged groups' experiences of Long Covid, and preliminary evidence suggests they may be under-represented in those who access formal care. We will conduct a pilot study in a defined geographical area in London, United Kingdom to test the feasibility of a community-based approach of identifying Long Covid cases that have not been clinically diagnosed and have not been referred to Long Covid specialist services. We will explore the barriers to accessing recognition, care, and support, as well as experiences of stigma and perceived discrimination.

methodsThis protocol and study materials were co-produced with a Community Advisory Board (CAB) made up primarily of people living with Long Covid. Working with voluntary organisations, a study leaflet will be distributed in the local community to highlight Long Covid symptoms and invite those experiencing them to participate in the study if they are not formally diagnosed. Potential participants will be assessed according to the study's inclusion criteria and offered the opportunity to participate if they fit them. Awareness of Long Covid and associated symptoms, experiences of trying to access care, as well as stigma and discrimination will be explored through qualitative interviews with participants. Upon completion of the interviews, participants will be offered a referral to the local social prescribing team to receive support that is personalised to them potentially including, but not restricted to, liaising with their primary care provider and the regional Long Covid clinic.

Indexed as

COVID-19Delivery of Health Care, IntegratedHumansPilot ProjectsPost-Acute COVID-19 SyndromeUnited Kingdom

Identifiers

PMID37471432
PMCPMC10358953
OpenAlexW4384925980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.